2025-05-22 06:01:36 pm | Source: reuters
India`s Sun Pharma posts quarterly profit rise on strong demand for rare disease drugs
Sun Pharmaceutical, India's largest drugmaker by revenue, reported a rise in adjusted quarterly profit on Thursday, driven by strong domestic demand for its drugs to treat rare diseases.
The Mumbai-based firm's consolidated profit before exceptional items and tax rose 24% to 36.16 billion rupees ($420.7 million) in the three months ended March 31.
Disclaimer:
The content of this article is for informational purposes only and should not be considered financial or
investment advice. Investments in financial markets are subject to market risks, and past performance is
not indicative of future results. Readers are strongly advised to consult a licensed financial expert or
advisor for tailored advice before making any investment decisions. The data and information presented
in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the
content of this article for any current or future financial references.
To Read Complete Disclaimer Click Here
Latest News
Market Commentary (closing) for 24th March 2026 by B...
Daily Market Commentary for March 24th 2026 By Siddh...
'People-centric Green Budget': Education Minister ha...
95 pc Indian women ready for AI-focused role
India building world?s largest 30 GW renewable park ...
Gas refineries operating at high capacity, 18,700 to...
India`s energy diversification strategy 'wise move':...
IPO Report : Powerica Ltd by by Choice Broking
Two LPG ships carrying 92,600 tonnes LPG on way to I...
Sensex jumps 1,372 points, Nifty near day`s high as ...
